Loading company…
Riskpilot
← Back to search
Sign in
Get full access
Speciallægeselskabet Groblos ApS
APS
Active
CVR 40336966
Svanevej 36
Medical specialists activities · NACE 8622
Est. 2019
5 employees
Watchlist
Share
Overview
Financials
People & ownership
Related companies
Revenue 2025
DKK 8,3M
+100% vs 2024
EBITDA margin
58.2%
+114% vs 2024
Equity ratio
39.1%
Financial strength
Net profit 2025
DKK 2,8M
+162% vs 2024
EBITDA — year on year
DKK millions
6M
5M
3M
2M
0M
0M
2021
0M
0%
2022
0M
0%
2023
2M
+200%
2024
5M
+150%
2025
Key figures
Annual report 2025
Revenue
DKK 8,3M
+100%
EBITDA
DKK 4,8M
+114%
Net profit
DKK 2,8M
+162%
Total assets
DKK 12,3M
+11%
Equity
DKK 4,8M
+119%
Employees
5
—
Company information
Legal name
Speciallægeselskabet Groblos ApS
CVR number
40336966
Legal form
Anpartsselskab
NACE code
8622 · Medical specialists activities
Founded
12. marts 2019
Share capital
DKK 40.000
Employees
5 (FTE)
VAT registered
No
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Virksomheden tegnes af direktøren.
Company purpose
Selskabets formål er at drive speciallægevirksomhed og virksomhed, der er naturligt forbundet hermed.
Contact
Address
Svanevej 36
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Medical specialists activities
Companies in Roskilde
All Denmark companies
Revenue
DKK millions
0M
2M
5M
7M
9M
0M
2021
0M
2022
0M
2023
4M
2024
8M
2025
EBITDA
DKK millions
0M
1M
3M
4M
6M
0M
2021
0M
2022
0M
2023
2M
2024
5M
2025
Income statement
DKK thousands
Item
2021
2022
2023
2024
2025
Revenue
227
266
360
4.142
8.266
Staff expenses
-0
-0
-0
-1.895
-3.036
EBITDA
227
266
360
2.247
4.807
Depreciation & amort.
-0
-0
-0
-845
-1.235
EBIT
227
266
360
1.402
3.572
Net financials
358
-245
287
-65
-51
Profit before tax
585
21
647
1.337
3.521
Tax
100
-16
113
287
766
Net profit
486
37
534
1.051
2.755
Balance sheet
DKK thousands
Item
2021
2022
2023
2024
2025
Total assets
1.116
1.126
1.467
11.103
12.332
Equity
987
1.024
1.269
2.199
4.819
Long-term debt
0
0
0
8.039
2.950
Short-term debt
129
102
199
804
4.489
Total debt
129
102
199
8.843
7.438
Financial ratios
5-year trend
EBITDA margin
58.2%
This company
15.8%
Market median
+268% vs market
2021
2025
Equity ratio
39.1%
This company
38.2%
Market median
+2% vs market
2021
2025
Return on equity
57.2%
This company
18.4%
Market median
+211% vs market
2021
2025
Net profit margin
33.3%
This company
8.1%
Market median
+311% vs market
2021
2025
Asset turnover
0.67×
This company
1.12×
Market median
-40% vs market
2021
2025
Debt / equity
1.56×
This company
0.62×
Market median
-152% vs market
2021
2025
Annual reports & filings
Annual report 2025
Filed via CVR / Virk · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
View
PDF
Management
Actively employed in the business
No data on file.
Board of directors
Non-executive oversight
No data on file.
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
Søren Solborg Bjerrum
Individual
100%
100%
2019
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
Speciallægeselskabet Groblos ApS
(this company)
Eyecare Denmark ApS
Auga Eye Center Sorø ApS
Board network connections
Board members of Speciallægeselskabet Groblos ApS also hold positions in
0
other companies.
Person
Role here
Other companies